PMC:7195088 / 30072-30328 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":89,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T23","span":{"begin":89,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"uberon_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T155","span":{"begin":6,"end":14},"obj":"Disease"},{"id":"T156","span":{"begin":94,"end":100},"obj":"Disease"},{"id":"T157","span":{"begin":198,"end":206},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A157","pred":"mondo_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T164","span":{"begin":21,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T165","span":{"begin":89,"end":93},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T166","span":{"begin":89,"end":93},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T167","span":{"begin":213,"end":218},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T400","span":{"begin":21,"end":26},"obj":"Chemical"},{"id":"T401","span":{"begin":141,"end":159},"obj":"Chemical"},{"id":"T402","span":{"begin":213,"end":218},"obj":"Chemical"}],"attributes":[{"id":"A400","pred":"chebi_id","subj":"T400","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A401","pred":"chebi_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A402","pred":"chebi_id","subj":"T402","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}

{"project":"LitCovid-sentences","denotations":[{"id":"T230","span":{"begin":16,"end":57},"obj":"Sentence"},{"id":"T231","span":{"begin":58,"end":124},"obj":"Sentence"},{"id":"T232","span":{"begin":125,"end":207},"obj":"Sentence"},{"id":"T233","span":{"begin":208,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"evere COVID-19. Open-label RCT (NCT04244591, recruiting). Primary endpoint: lower Murray lung injury score at days 7 and 14.\n• Comparison of methylprednisolone vs. standard of care in patients with COVID-19. Open-label RCT (NCT04273321, recruiting). Primar"}